These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8512774)

  • 1. Renal osteodystrophy and hypercalcemia.
    Cohen-Solal M; Sebert JL
    Curr Opin Rheumatol; 1993 May; 5(3):357-62. PubMed ID: 8512774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health and vascular calcification relationships in chronic kidney disease.
    Spasovski GB
    Int Urol Nephrol; 2007; 39(4):1209-16. PubMed ID: 17899431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic evolution of bone disease 6 months after successful kidney transplantation.
    Cruz EA; Lugon JR; Jorgetti V; Draibe SA; Carvalho AB
    Am J Kidney Dis; 2004 Oct; 44(4):747-56. PubMed ID: 15384027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treatment of renal osteodystrophy on bone histology.
    Malluche HH; Mawad H; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S157-63. PubMed ID: 18988701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasonography methods in the diagnosis of renal osteodystrophy].
    Tomić-Brzac H; Pavlović D
    Acta Med Croatica; 2004; 58(1):43-9. PubMed ID: 15125393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation.
    Borchhardt K; Sulzbacher I; Benesch T; Födinger M; Sunder-Plassmann G; Haas M
    Am J Transplant; 2007 Nov; 7(11):2515-21. PubMed ID: 17725680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adynamic bone disease in patients with uremia.
    Fournier A; Yverneau PH; Hué P; Said S; Hamdini N; Eldin HM; Mohageb S; Oprisiu R; Marie A; Solal ME
    Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):396-410. PubMed ID: 8076143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative phosphate binders in dialysis patients: calcium carbonate.
    Slatopolsky E; Weerts C; Stokes T; Windus D; Delmez J
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):35-41. PubMed ID: 3602677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients.
    Lehmann G; Ott U; Stein G; Steiner T; Wolf G
    Transplant Proc; 2007 Dec; 39(10):3153-8. PubMed ID: 18089342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with calcimimetics in kidney transplantation.
    Morales E; Gutierrez E; Andres A
    Transplant Rev (Orlando); 2010 Apr; 24(2):79-88. PubMed ID: 20303456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum and renal osteodystrophy.
    Sherrard DJ
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):5-11. PubMed ID: 3299591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R
    Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytokines in renal osteodystrophy.
    Monier-Faugere MC; Malluche HH
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):327-32. PubMed ID: 9263681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.